Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11339848 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Mercury Chelation to Treat Autism
Conditions: Autism;   Asperger's Disorder;   Child Development Disorders, Pervasive
Intervention: Drug: DMSA

Indicates status has not been verified in more than two years